This is the first report that shows PRK as a potential drug against Mtb. The enhanced efficacy of PRK on the host infection models and its augmented response in combination with the therapy drugs attest to its promise as a potential drug against tuberculosis. This evidence concerns the gene PLK3 and tuberculosis.